(19)
(11) EP 4 823 440 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24840895.7

(22) Date of filing: 10.12.2024
(51) International Patent Classification (IPC): 
A61B 5/377(2021.01)
A61N 2/00(2006.01)
A61B 5/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/4064; A61N 2/006; A61B 5/4088; A61B 5/7275; A61B 5/377; A61B 5/4842; A61B 5/7246
(86) International application number:
PCT/IB2024/062443
(87) International publication number:
WO 2025/126038 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 US 202363608422 P

(71) Applicant: Quantalx Neuroscience Ltd
Kfar Sava 4453001 (IL)

(72) Inventors:
  • FOGEL, Hilla
    7316000 Mazor (IL)
  • DOLEV, Iftach
    4281000 Zur Moshe (IL)
  • LEVY-LAMDAN, Ofri
    5253165 Ramat Gan (IL)
  • ZIFMAN, Noa
    4424118 Kfar-Saba (IL)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)

   


(54) IDENTIFYING CEREBROVASCULAR DISEASE AND MEDIAL TEMPORAL ATROPHY